Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Therasse

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomyI S Fentiman, M-R Christiaens, R Paridaens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome?H Bonnefoi, S Diebold-Berger, P Therasse, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 25, 2010
Embryotoxicity of human sera from patients treated with isotretinoinG Van Maele-Fabry, P Therasse, E Lenoir, et al.
Journal of the National Cancer Institute|February 3, 2000
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of CanadaP Therasse, S G Arbuck, E A Eisenhauer, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2008
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)E A Eisenhauer, P Therasse, J Bogaerts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)P Saiag, R Gutzmer, P A Ascierto, et al.
Tumori|July 25, 1998
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative GroupJ Wils, T Sahmoud, A Sobrero, et al.
Advances in Experimental Medicine and Biology|December 14, 2006
TuBaFrost: European virtual tumor tissue bankingP H J Riegman, M H A Oomen, W N M Dinjens, et al.
European Journal of Cancer (Oxford, England : 1990)|October 10, 2006
TuBaFrost 2: Standardising tissue collection and quality control procedures for a European virtual frozen tissue bank networkM M Morente, R Mager, S Alonso, et al.
Advances in Experimental Medicine and Biology|December 14, 2006
Virtual microscopy in virtual tumor bankingM Isabelle, I Teodorovic, J W Oosterhuis, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomyI S Fentiman, M-R Christiaens, R Paridaens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome?H Bonnefoi, S Diebold-Berger, P Therasse, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 25, 2010
Embryotoxicity of human sera from patients treated with isotretinoinG Van Maele-Fabry, P Therasse, E Lenoir, et al.
Journal of the National Cancer Institute|February 3, 2000
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of CanadaP Therasse, S G Arbuck, E A Eisenhauer, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2008
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)E A Eisenhauer, P Therasse, J Bogaerts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)P Saiag, R Gutzmer, P A Ascierto, et al.
Tumori|July 25, 1998
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative GroupJ Wils, T Sahmoud, A Sobrero, et al.
Advances in Experimental Medicine and Biology|December 14, 2006
TuBaFrost: European virtual tumor tissue bankingP H J Riegman, M H A Oomen, W N M Dinjens, et al.
European Journal of Cancer (Oxford, England : 1990)|October 10, 2006
TuBaFrost 2: Standardising tissue collection and quality control procedures for a European virtual frozen tissue bank networkM M Morente, R Mager, S Alonso, et al.
Advances in Experimental Medicine and Biology|December 14, 2006
Virtual microscopy in virtual tumor bankingM Isabelle, I Teodorovic, J W Oosterhuis, et al.
Pageof 6